Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Atossa Therapeutics ( (ATOS) ) has shared an announcement.
On December 19, 2025, Atossa Therapeutics stockholders approved an amendment to the company’s Certificate of Incorporation authorizing a reverse stock split of its common stock at a ratio between 5:1 and 20:1, with 33.7 million votes in favor, 27.9 million against and a small number of abstentions. Following this approval, the board of directors set a 15:1 reverse stock split to take effect at 12:01 a.m. Eastern Time on February 2, 2026, after which every 15 existing shares will be automatically combined into one new share, the stock will begin trading on a split-adjusted basis under a new CUSIP while retaining the ATOS ticker, fractional shares will be cashed out based on the January 30, 2026 closing price, and proportional adjustments will be made to equity awards, share reserves and preferred stock conversion terms, effectively reducing the share count and consolidating the company’s capital structure for existing shareholders.
The most recent analyst rating on (ATOS) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Atossa Therapeutics stock, see the ATOS Stock Forecast page.
Spark’s Take on ATOS Stock
According to Spark, TipRanks’ AI Analyst, ATOS is a Neutral.
The score is primarily constrained by weak financial performance (no revenue, ongoing losses and cash burn, shrinking equity) and bearish technical signals (below key moving averages with negative MACD). Positive FDA-related pipeline events provide an offset, but valuation remains pressured due to negative earnings and no dividend support.
To see Spark’s full report on ATOS stock, click here.
More about Atossa Therapeutics
Atossa Therapeutics is a Nasdaq-listed biotechnology company that issues common stock and Series B Convertible Preferred Stock, with its shares trading under the symbol ATOS on the Nasdaq Stock Market.
Average Trading Volume: 1,199,322
Technical Sentiment Signal: Sell
Current Market Cap: $82.94M
Learn more about ATOS stock on TipRanks’ Stock Analysis page.